Search Articles — Sudonull

Search Results

From other projects

JellyThin: a new weight loss trend based on jelly texture

https://ymaho.com/jellythin-a-new-weight-loss-trend-based-on-jelly-texture

JellyThin — a weight loss trend based on puddings and kissels. We analyze the mechanics, risks for the gastrointestinal tract, brand margins, and forecast. Read expert analysis.

VER-01 breakthrough therapy FDA: non-opioid analgesic

https://ymaho.com/ver-01-breakthrough-therapy-fda-non-opioid-analgesic

FDA granted breakthrough therapy status to non-opioid analgesic VER-01. The drug is more effective than opioids and safer for the gastrointestinal tract. Details in the article.

Benralizumab for eosinophilic esophagitis: EMA approval 2026

https://ymaho.com/benralizumab-for-eosinophilic-esophagitis-ema-approval-2026

Analysis of EMA approval of benralizumab for the treatment of eosinophilic esophagitis: phase 3 MESSINA data, comparison with dupilumab, risks and prospects. Read.

Trending Now